Top Markets
#1 Islamic Coin Islamic Coin +151.30%
#2 Akedo Akedo +77.68%
#3 Glidr Glidr +51.75%
#4 DOVU DOVU +48.65%
#5 Cross Cross +44.14%
#6 Black Phoenix Black Phoenix +33.98%
#7 Velvet Velvet +25.65%
#8 Cap Cap +25.20%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.99%
#10 Palladium Network Palladium Network +12.46%
Coin of the day
Islamic Coin Islamic Coin
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc.

HEPA
Classificação em ações #39072
Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is... Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is dedicated to developing therapeutic interventions for chronic hepatic ailments. Central to their efforts is Rencofilstat, a cyclophilin inhibitor that has successfully concluded Phase 2a clinical trials. This compound operates by disrupting multiple pathological pathways implicated in the worsening of liver disease. It is currently progressing through clinical development for non-alcoholic steatohepatitis (NASH) and is additionally being explored in nonclinical research for its potential to reduce liver fibrosis and lessen hepatocellular carcinoma tumor loads in experimental models of NASH. Moreover, Rencofilstat has exhibited antiviral properties against hepatitis B, C, and D viruses through diverse mechanisms. The company, established in 2013 and situated in Edison, New Jersey, rebranded as Hepion Pharmaceuticals, Inc. in July 2019, having previously operated as ContraVir Pharmaceuticals, Inc.
Preço da ação
$0.0568
Última sincronização: 2026-08-13
Valor de mercado
$661.36K
Variação (1 dia)
11.37%
Variação (1 ano)
-5.33%
País
US
Negociar Hepion Pharmaceuticals, Inc. (HEPA)

Categoria

Healthcare
Preço HEPA com a capitalização de mercado de B
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
HEPA
$0.0568
Capitalização de mercado de Hepion Pharmaceuticals, Inc.(HEPA)
Valor de mercado: $661.36K
Em August 2026, Hepion Pharmaceuticals, Inc. tem uma capitalização de mercado de $661.36K. Isso faz com que Hepion Pharmaceuticals, Inc. seja a 39072nd empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Hepion Pharmaceuticals, Inc. de 2014 a 2026
HEPA comparado com o topo de 5 mais populares stocks
Preço para HEPA Ativo B Capitalização de mercado de B Resultados
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$469,742 $661.36K
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.470T +827,009,900.33%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$383,647 $661.36K
Apple Inc. Apple Inc.
AAPL
$4.467T +675,434,042.20%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$358,510 $661.36K
Alphabet Inc. Alphabet Inc.
GOOG
$4.174T +631,179,244.65%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$317,775 $661.36K
Microsoft Corporation Microsoft Corporation
MSFT
$3.700T +559,462,337.44%
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.
$245,140 $661.36K
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.854T +431,584,807.66%